BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Modular Medical Appoints James “Jeb” Besser as Chief Executive Officer

  Modular Medical, Inc. announced that its board of directors has appointed James “Jeb” Besser as Chief Executive Officer.

  February 24, 2022

   · 

  4 min read
• Genetown

  Scipher Medicine Closes $110 Million Financing

  Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, announced the completion of a $110 million financing.

  February 24, 2022

   · 

  3 min read
• Biotech Beach

  Element Biosciences Partners with Dovetail Genomics to Validate its Proximity Ligation-Based NGS Library Prep Solutions for Epigenetics on Element’s AVITI™ System

  Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Dovetail Genomics demonstrating the value and performance of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System.

  February 24, 2022

   · 

  3 min read
• Business

  PAVmed Appoints Shaun O’Neil as Chief Operating Officer

  PAVmed Inc. today announced the appointment of Shaun O’Neil to serve as Executive Vice President and Chief Operating Officer.

  February 24, 2022

   · 

  6 min read
• Business

  HMNC Brain Health Appoints Dr. Bertram Müller-Myhsok as Head of Precision Psychiatry

  HMNC Brain Health, a clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced the appointment of Dr. Bertram Müller-Myhsok as its new Head of Precision Psychiatry, effective March 1, 2022.

  February 24, 2022

   · 

  4 min read
• Genetown

  Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

  Wave Life Sciences Ltd. announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Thursday, March 3, 2022, to discuss its fourth quarter and full year 2021 financial results and provide a business update.

  February 24, 2022

   · 

  1 min read
• SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test

  SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for SeekInCare® Cancer Detection Kit and is now ready to launch this test in European markets.

  February 24, 2022

   · 

  3 min read
• Business

  AmerisourceBergen Adds Freight Management Capabilities Powered by TRIOSE, Inc. for Hospital & Health System Customers

  Today, global healthcare company AmerisourceBergen announced the addition of TRIOSE ’s freight management capabilities to its suite of commercial solutions.

  February 24, 2022

   · 

  4 min read
• Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharmaceuticals Corp.

  Juno Pharmaceuticals Corp announced that it has received a strategic growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare growth equity firm.

  February 24, 2022

   · 

  2 min read
• New Study in Journal of Pharmaceutical Analysis Marries Modern Science with Traditional Knowledge to Decipher Anti-Diarrheal Effect of Cashew Stem Bark Extract

  Anacardium occidentale, the common cashew tree, is a plant that has long been recognized in traditional medicine systems for its therapeutic potential.

  February 24, 2022

   · 

  3 min read